Adaptimmune, GSK to Develop and Commercialise Novel Cell-Based Therapies|
Monday, June 02, 2014
Adaptimmune enters a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialisation of its lead clinical cancer programme.
Symphogen to Report Preliminary Safety Data from a Phase 1 Study of Sym004
Friday, May 30, 2014
Data will be presented at the upcoming 2014 ASCO Annual Meeting in Chicago.
Rockland Immunochemicals Expands into 60,000 Square Foot Facility
Thursday, May 29, 2014
Company expands laboratories to keep pace with growth.
Stanford Researchers Discover Immune System’s Rules of Engagement
Saturday, May 24, 2014
Study finds surprising similarities in the way immune system defenders bind to disease-causing invaders.
HIV Vaccine Awareness Day
Thursday, May 22, 2014
Early stage vaccine clinical trials are expected to begin in South Africa in early 2015.
Key Genetic Link Between Chronic Pain Conditions Discovered
Wednesday, May 21, 2014
Research from at King’s College London suggests that some people may be genetically predisposed to suffer from conditions of this type.
FDA Grants Breakthrough Designation for Multiple Myeloma Drug
Tuesday, May 20, 2014
Bristol-Myers Squibb and AbbVie received the designation for Elotuzumab, an investigational humanized monoclonal antibody for multiple myeloma.
Prostrate Cancer Drug Moves into Human Clinical Trials
Monday, May 19, 2014
ADC Therapeutics announced that it has selected its first IND candidate under its joint development agreement with MedImmune.
Stanford Research Leads to New Understanding of How Cells Grow and Shrink
Saturday, May 17, 2014
Researchers use new techniques to document how cells can conceal growth and then suddenly swell up.